Immugen Pharma LLC is a groundbreaking brand that specializes in innovative solutions for women's health. With a focus on menopause and the genitourinary syndrome, Immugen is at the forefront of research and development in this field. The brand's journey began with a pivotal observation made by Dr.

Travis while practicing medicine in Jamaica. He noticed a correlation between the low prevalence of HIV/AIDS in Jamaica and the widespread use of cannabis among at-risk populations. This discovery led to a successful R21NIH grant that aimed to explore the potential of non-psychoactive derivatives of THC in improving the barrier function of vaginal tissue.

Immugen's research has since resulted in a patent for a non-hormonal treatment of the genitourinary syndrome of menopause. Recent studies have validated the efficacy of their lead compound, which showed significant improvements in tissue thickness. With their cutting-edge approach and commitment to women's health, Immugen is revolutionizing the field and providing women with effective and safe treatment options.

To learn more about Immugen and their breakthrough solutions, visit their website or contact them directly